Founderscrowd Special Edition: Biostate AI Investor Webinar Announcement

Dear Founderscrowd Community,

I'm Alberto, and today, we're making an exception to our usual newsletter format. We've received numerous inquiries about Biostate AI, and after much anticipation, we've secured an exclusive opportunity for you to engage directly with their leadership team.​

What Is Biostate AI?

Biostate AI is at the forefront of revolutionizing healthcare by integrating AI with RNA sequencing. Their platform analyzes biological and clinical samples to predict diseases before they manifest, enabling personalized treatments tailored to individual genetic profiles. This approach not only enhances diagnostic accuracy but also optimizes treatment efficacy.​

Impressive Traction

• $8M+ raised from top-tier investors in the biotech sector.

• Strategic partnerships with leading institutions such as Harvard, Cornell, Berkeley, and MD Anderson.

• A portfolio of 12 pending patents and collaborations with esteemed organizations like the Accelerated Cure Project .

Investor Webinar: A Unique Opportunity

As Biostate AI's crowdfunding campaign nears its close in just 10 days, we're thrilled to invite you to an exclusive investor webinar. This session will provide insights into their innovative approach and the future of healthcare AI.​

Event Details:

• Date & Time: [Insert Date & Time]

• Speakers:

  • Paul Rothemund, VP of Research

  • Timothy Kassis, Head of AI

Agenda:

• Introduction to Biostate AI's clinical focus.

• Deep dive into their AI-driven approach.

• Live Q&A session.

Registration Link: Biostate AI Investor Webinar

Why Attend?

This webinar offers a rare chance to interact with the minds behind a company poised to become a leader in healthcare innovation. With only 10 days left in their campaign, now is the time to learn more and consider joining their journey.​

We look forward to your participation and to exploring this exciting opportunity together.​

Warm regards,

Alberto
Founder, Founderscrowd